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Available online 28 April 2013Abstract Perinatal hypoxia–ischemia (HI) results in brain injury, whereas mild hypoxic episodes result in preconditioning, which
can significantly reduce the vulnerability of the brain to subsequent severe hypoxia–ischemia. Hypoxic-preconditioning (PC) has
been shown to enhance cell survival and differentiation of progenitor cells in the central nervous system (CNS). The purpose of this
study was to determine whether pretreatment with PC prior to HI stimulates subventricular zone (SVZ) proliferation and
neurogenesis in newborn piglets. One-day-old piglets were subjected to PC (8%O2/92%N2) for 3 h and 24 h laterwere exposed to HI
produced by combination of hypoxia (5% FiO2) for a pre-defined period of 30 min and ischemia induced by a period of 10 min of
hypotension. Here we demonstrate that SVZ derived neural stem/progenitor cells (NSPs) from PC, HI and PC + HI piglets proliferated
as neurospheres, expressed neural progenitor and neurodevelopmentalmarkers, and that greater proportion of the spheres generated
are multipotential. Neurosphere assay revealed that preconditioning pretreatment increased the number of NSP-derived
neurospheres in SVZ following HI compared to normoxic and HI controls. NSPs from preconditioned SVZ generated twice as many
neurons and astrocytes in vitro. Injections with 5-Bromo-2-deoxyuridine (BrdU) after PC revealed a robust proliferative response
within the SVZ that continued for oneweek. PC also increased neurogenesis in vivo, doublecortin positive cells with migratory profiles
were observed streaming from the SVZ to striatum and neocortex. These findings show that the induction of proliferation and
neurogenesis by PC might be a positive adaptation for an efficient repair and plasticity in the event of a hypoxic–ischemic insult.
© 2013 Elsevier B.V. All rights reserved.Abbreviations: BrdU, 5-bromo-2-deoxyuridine; Dcx, doublecortin;
GFAP, glial fibrillary acidic protein; PC, hypoxic-preconditioning; HI,
hypoxia–ischemia; SVZ, subventricular zone; NSPs, neural stem/
progenitor cells
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Hypoxic–ischemic (HI) injury to the prenatal and perinatal
brain is a major contributor to global child mortality and
morbidity (Volpe, 2001). Perinatal hypoxic–ischemic injury
affects between 1 and 8 per 1000 full-term infants and nearly
60% of low birth-weight (premature) infants (Vannucci, 2000;
Wagner et al., 1999). Birth asphyxia is the cause of 20 to 50% of
all neonatal deaths worldwide. Approximately 25% of children
who survive birth asphyxia develop permanent neurological
670 J. Ara, S. De montpellierdysfunctions including cerebral palsy, mental retardation,
learning disabilities, and epilepsy (Ashwal, 1993; Vannucci,
2000; Volpe, 2001; Wagner et al., 1999). Although the exact
cause of HI encephalopathy is not always identified, anteced-
ents include prolapsed umbilical cord, uterine rupture,
placental damage, maternal hypotension and acute neonatal
and maternal hemorrhage. The outcome from HI injury is
further influenced by a variety of factors that include the
gestational age as well as the nature, severity, and duration of
hypoxic–ischemic insult. Despite advances in supportive care,
no effective treatment strategies for HI brain injury are
available at present and only partial benefit from hypothermia
for neonates with moderate hypoxic–ischemic injury has been
realized (Edwards et al., 2010).
Hypoxic-preconditioning (PC) is a phenomenon in which
mild episodes of hypoxia induce a significant increase in
resistance of neurons to subsequent damaging influences of
severe hypoxia–ischemia (Dirnagl et al., 2003; Gidday, 2006;
Ran et al., 2005). This initial PC stimulus triggers a cascade of
endogenous adaptive mechanisms resulting in the develop-
ment of tolerance. Although the molecular mechanisms
of PC-induced neural hypoxic–ischemic tolerance are not
completely understood, recent studies showed that PC in
adult and neonatal rodents induced by brief carotid or middle
cerebral artery occlusions afford neuroprotection when it
precedes the lethal ischemic insult by 1–7 days (Gidday et al.,
1994; Kitagawa et al., 1991; Stagliano et al., 1999; Vannucci
et al., 1998).We have recently demonstrated for the first time
the protective efficacy of hypoxic-preconditioning against
hypoxic–ischemic injury in newborn piglet model (Ara et al.,
2011).
In the last two decades, our knowledge concerning the
underlying molecular basis of PC has substantially grown, and
there is hope to potentially imitate the induction of an
endogenous neuroprotective state in patients with a high risk
of cerebral ischemia. Research into PC has led to the idea of
prophylactically inducing protection in patients such as those
undergoing brain and heart surgery and those with transient
ischemic attack or subarachnoid hemorrhage. An even greater
potential of the PC paradigm lies in its role as an experimental
strategy to identify the mechanisms of endogenous brain
neuroprotection. The major goal of such research is to
understand how the brain protects itself against shortages in
substrate delivery or other injurious challenges, with the
explicit purpose of therapeutically exploiting such mechanisms
by boosting or exogenously substituting endogenous protec-
tants following HI.
Neural stem/progenitor cells (NSPs) are multipotent pre-
cursors that self-renew and retain the ability to differentiate
into neurons, astrocytes and oligodendrocytes (Okano, 2002a,
b). They reside throughout life in neurogenic zones such as the
subventricular zone (SVZ) and subgranular zone (SGZ) of the
hippocampal dentate gyrus (Palmer et al., 1995; Reynolds et
al., 1992; Sanai et al., 2004). Recent advances in stem cell
research, including selective expansion of neural stem/
progenitor cells (NSPs) in vitro, identification of NSPs in the
brain and detection of neurogenesis in brain, have laid the
groundwork for the development of novel therapies aimed at
inducing regeneration in the damaged central nervous system
(CNS). Two main strategies have evolved from our recent
understanding of stem cell biology. The first one consists of
grafting NSPs to replace the dying cells; the second aims atrecruiting endogenous stem cells or progenitors to the lesion
sites (Emsley et al., 2005; Scheffler et al., 2006).
There is increasing evidence to support the existence of
endogenous compensatory mechanisms, which are activated in
response to injury and disease (Li and Chopp, 1999; Li et al.,
1997; Lindvall and McKay, 2003). Brain injury caused by
cerebral ischemia, seizures, or traumatic injury (Dempsey et
al., 2003; Gould et al., 1997; Gu et al., 2000; Jin et al., 2001;
Liu et al., 1998; Parent et al., 1997) can stimulate neurogenesis
in SVZ and dentate gyrus (DG) of hippocampus, and direct the
migration of newly produced neurons towards affected regions
(Arvidsson et al., 2002; Hicks et al., 2007; Jin et al., 2003;
Nakatomi et al., 2002; Parent et al., 2002a,b; Sun et al., 2007).
Several studies demonstrate that newborn neurons migrate
toward ischemic lesions, where they might participate in brain
repair and functional recovery (Jin et al., 2003; Nakatomi et
al., 2002; Parent et al., 2002a; Sun et al., 2007). However, the
number of newly generated neurons remains insufficient to
restore normal brain function (Arvidsson et al., 2002; Bjorklund
and Lindvall, 2000). To overcome this limitation, the manip-
ulation of NSPs has developed into a key strategy for brain
repair. The proliferation potential of progenitor cells can be
enhanced by external stimulators, e.g. environmental enrich-
ment (Komitova et al., 2002), caloric restriction, exercise and
growth factors (Dempsey et al., 2003; Jin et al., 2002; Sun et
al., 2003) and by hypoxic preconditioning (Li et al., 2010; Liu et
al., 1998; Naylor et al., 2005). PC triggers an adaptive response
that prepares the brain to minimize damage and promote
regeneration in the event of future ischemic insult. The
investigation of endogenous pathways by which the brain
protects itself from ischemia represents a novel paradigm for
research into cerebral hypoxia–ischemia — one that holds
promise for identifying unique hypoxic–ischemic therapeutics.
In the present study, we used a piglet model of cerebral
hypoxia–ischemia; a powerful in vivo model which emulates
important clinical similarities to human situation of birth
asphyxia, to evaluate the NSP cell proliferation, differentia-
tion and neurogenesis in SVZ of newborn piglets subjected to
PC and severe hypoxia–ischemia subsequent to PC. Although
no animal model can perfectly replicate the complexity of HI
events that occur in the human neonate, the pigletmodel used
in this study offers distinct advantages in replicating specific
mechanisms, morphology and maturational stages relevant to
age dependent injury responses. Piglets, with features of a
neonatal human brain such as overall shape, gyral pattern,
gray/white matter distribution, degree of myelination, and
brain growth spurt (Armstead and Kurth, 1994; Dickerson and
Dobbing, 1966; Hoehner et al., 1994), offer an appropriate
model to study injury mechanisms and treatment approaches
for cerebral ischemic injury. A major challenge facing trans-
lational efforts with respect to transplantation of stem/
progenitor cells to the CNS are the need for more predictive
animal models. The use of a non-rodent, non-inbred model,
such as the piglet, may better predict success for NSP trans-
plantation in the human patients. Piglets are advantageous as
models of NSP therapy because they have heterogeneous
genetic backgrounds, are developmentally equivalent to brain
growth, maturation and differentiation to that of the human
at birth, and have larger body sizes, providing better
opportunity for long-term safety studies and surgical manip-
ulations (Flecknell et al., 1982; Haaland et al., 1997). Porcine
neural progenitors have been used as donor cells and are
Fig. 2 Neural stem/progenitor cells derived from preconditioning and hypoxic–ischemic piglet SVZ express neural progenitor and
neural differentiation markers. (A) Immunofluorescence staining of neurospheres showing expression of stem/progenitor cell marker,
Sox2 and proliferation marker Ki67. (B) RT-PCR of undifferentiated and differentiated neurospheres showing gene expression of
CD133, Dcx, Ki67, Sox2, nestin, Tuj1 and GFAP in NX, HI and PC + HI piglet NSPs. A 100 bp ladder is at the left of the gel.
Fig. 1 (A) Morphological and phenotypic properties of primary neural stem/progenitor cells derived from subventricular zone (SVZ)
of newborn piglet brain. (a) Phase contrast image of primary SVZ neurosphere formation in culture from normoxic (NX),
preconditioning (PC), hypoxic–ischemic (HI) and preconditioning + hypoxic–ischemic (PC + HI) piglet brain. (b) Differentiated
neurospheres from NX, PC, HI and PC + HI piglet SVZ. (c) Nestin immunoreactivity (green) and Hoescht-labeled nuclei (blue) in
undifferentiated neurospheres. (B) Hypoxic-preconditioning increases the number of colony-forming neural stem/progenitor cells
derived from SVZ of neonatal piglet brain. Bar graph shows the quantification of secondary spheres generated from NX, PC, HI and
PC + HI. ⁎P b 0.05 NX vs PC, NX vs HI and NX vs PC + HI; #P b 0.05 HI vs PC + HI using ANOVA and Bonferroni's post-hoc tests. Values are
the mean number of spheres generated/5000 SVZ cells ± SD of four independent experiments, derived from four different neural
stem/progenitor cell preparations from four individual piglet SVZ's/group.
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Table 1 Percentage of neurons, astrocytes and
oligodendrocytes generated from NSPs of newborn piglet
brain.
Groups Percentage of cells
Neurons
(Tuj-positive)
Astrocytes
(GFAP-positive)
Oligodendrocytes
(O4-positive)
Normoxia 42.0 ± 5.0 32.0 ± 4.9 13.0 ± 2.1
PC 66.0 ± 8.0 a 40.0 ± 7.5 a 10.0 ± 1.8
HI 55.0 ± 10.2 a 35.0 ± 5.0 a 9.0 ± 1.5
PC + HI 64.0 ± 12.0 a b 42.0 ± 7.2 a b 10.0 ± 1.2
a P b 0.05 Nx vs PC, NX vs HI and NX vs PC + HI.
b P b 0.05 HI vs PC + HI.
672 J. Ara, S. De montpelliercapable of engrafting into mammalian CNS after transplanta-
tion (Armstrong et al., 2003; Isacson and Deacon, 1996). These
cells, therefore, provide a large animal comparison for human
NSPs and have been considered as an alternative source for
donor material. Thus, the studies conducted in piglet brains,
which resemble those of humans in size and developmental
trajectory, offer an important translational bridge from in
vitro and rodent models to human patients.
Here, we report for the first time in a large animal model
that PC pretreatment prior to hypoxia–ischemia increases
proliferation, differentiation, and neurogenesis in SVZ of
newborn brain. Our studies show that PC performed 24 h prior
to hypoxia–ischemia significantly increased NSP cell prolifera-
tion both in vitro and in vivo and increased neurogenesis in vivo.
These results suggest that the stimulation of proliferation and
neurogenesis by PC might be a positive adaptation for an
efficient repair in the event of an hypoxic–ischemic insult and
this model might be a useful paradigm for the preclinical
evaluation of novel cell based therapies for hypoxic–ischemic
brain damage.
Materials and methods
Animals
All experimental animal protocols were approved by the
Drexel University College of Medicine IACUC Committee and
performed in accordance with US National Institutes of HealthFig. 3 Piglet SVZ neural stem/progenitor cells derived from p
multipotent. Single primary EGF and bFGF2-generated spheres w
neurons), GFAP (a marker for astrocytes) and O4 (a marker for im
derived spheres with Tuj1 (green) and GFAP (red) or Tuj1 (red)
differentiated NSPs are multipotent with populations of neurons,
immunoreactive for a single marker (80%).guidelines as outlined in the Policy on Humane Care and Use of
Laboratory Animals (NIH publication August, 2002). All efforts
were made to minimize animal suffering and to reduce the
number of animals used.Hypoxic-preconditioning
Hypoxic-preconditioning was performed as described by Ara et
al. (2011). Briefly, one-day-old female piglets were placed in a
large plexiglass hypoxia chamber (Coy Laboratory products
Inc., Grass Lake, MI) throughwhich 8%O2/92%N2was circulated
for 3 h. Female piglets were chosen for these studies because inreconditioned and hypoxic–ischemic neonatal piglet SVZ are
ere stained with lineage-specific markers, Tuj1 (a marker for
mature oligodendrocytes). Double immunolabeling of clonally
and O4 (green) or GFAP (red) and O4 (green) reveals that
astrocytes and oligodendrocytes. Majority of these cells were
673Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitorsour preliminary studies we have found that females are more
resistant to hypoxia–ischemia than males. Control piglets were
exposed to 21% O2. After hypoxic-preconditioning or normoxia,
all animals were returned to the animal room for 1, 3 and
7 days.Cerebral hypoxia–ischemia
Cerebral hypoxia–ischemia was induced in newborn female
piglets (one-day-old and average weight of 1.5 kg) as
described previously (Ara et al., 2011). Briefly, piglets were
anesthetized with 4% isofluorane, then intubated and venti-
lated. Inspired oxygen (FiO2) and peak inspiratory pressure
(PIP) were adjusted to maintain arterial oxygen saturation
(SaO2) 95–98% and arterial pCO2 35–45 mm Hg. An umbilical
artery was aseptically cannulated for monitoring of blood
pressure and arterial blood gases. Core body temperature
was maintained at 38–39 °C. Heart rate (HR), mean arterial
blood pressure (MABP), temperature and SaO2 weremonitored
and recorded for the duration of the experiment. A digital
electroencephalogram (EEG) device was used to monitor EEG
amplitude and frequency. After intubation, the use of
isofluorane was discontinued, and fentanyl (0.05 mg/kg) and
pancuronium (0.3 mg/kg) were given as needed to maintain
anesthesia. Hypoxia–ischemia was induced by decreasing FiO2
to 5% and continued for 40 min. FiO2 was decreased or
increased by 1% increments during the insult to maintain HR
(N130 beats/min) and MABP (N70% baseline). Hypotension
was induced for the final 10 min of the insult by decreasing
FiO2 until the MABP was b70% of baseline. Hypoxia was
terminated by resuscitation with 100% oxygen for 10 min to
mimic the clinical situation. Furthermore, we chose 100%
oxygen because in asphyxiated newborn piglets, microcircu-
lation in the brain and normalization of metabolic markers as
glutamate are restored faster with 100% than 21% O2 (Solas et
al., 2001). Following 10 min of 100% FiO2, the ventilator rate
and FiO2 were reduced to maintain PaO2 within the normal
range until the piglet was able to breathe spontaneously,
at which time the piglet was extubated. Animals were
recovered for 1, 3 and 7 days. During the recovery period
each piglet was neurologically assessed using the method
described by Thoresen et al. (1996) approximately every
8 h for the first 24 h and then at 48 h, 72 h and 7 days.
After reoxygenation periods, animals were anesthetized
and perfused transcardially for histological and immuno-
histochemical analysis.Experimental groups
Piglets were divided into four groups (n = 4 or 5 in each group
at each time point): (1) control normoxic group (NX): piglets
were exposed to 21% O2 for 3 h; (2) hypoxic preconditioned
(PC) group: piglets were subjected to (8%O2/ 92%N2) for 3 h;
(3) hypoxic–ischemic (HI) group: animals were subjected to 5%
FiO2 for 40 min with 10 min hypotension; and (4) hypoxic
preconditioned + hypoxic–ischemic (PC + HI) group: the pig-
lets were preconditioned with 8%O2/ 92%N2 24 h prior to
hypoxia–ischemia (5% FiO2, 40 min with 10 min hypotension).
The piglets in all these four groups were recovered for 1, 3 and
7 days.Neurosphere preparation
Neurospheres were prepared from one-day-old piglets
according to Ara et al. (2010). Briefly, piglets from above
mentioned four groups were anesthetized after 24 h recovery
using 4% isofluorane followed by intravenous injection of
euthesol solution at a dose of 1.75 mg/kg. The piglets were
sacrificed by decapitation and their brains were removed using
aseptic techniques. Decapitation under anesthesia using intra-
venous injection of euthesol euthanasia solution at an overdose
was performed to ensure rapid loss of consciousness combined
with the ability to collect brain tissue that is anatomically
undamaged and chemically uncontaminated. This method of
euthanasia is consistent with the recommendations of the Panel
on Euthanasia of the American Veterinary Medical Association
and was approved by the Drexel University College of Medicine
IACUC committee.
The SVZ was isolated, placed in chilled sterile PBS with
0.6% glucose, and mechanically minced (one SVZ per prepa-
ration for each group). The tissue pieces were incubated in
Hank's balanced salt solution containing 0.1% trypsin with
0.04% DNAase for 20 min at 37 °C. Following three washes in
0.04% DNAase, the tissue was triturated, passed through a
40 μm cell strainer and the number of viable cells was
determined with a hemocytometer by exclusion of 0.1%
Trypan Blue dye. The cells were then plated as a single cell
suspension at a density of 3.75 × 106 cells into 75 cm2 cell
culture flasks in 10 ml DMEM/HAMS F12 supplemented with
20 ng/ml epidermal growth factor (EGF), 20 ng/ml human
basic fibroblast growth factor 2, (bFGF-2), 2% B-27 supplement
(Invitrogen Corporation, San Diego, CA) and penicillin G/
streptomycin sulphate/amphotericin (1:100; Mediatceh Inc.,
Manassas, VA). After 20 days in culture, neurospheres were
generated and floated in the culture. Cultures were passaged
every 2 weeks by mechanical tituration of the spheres to yield
a single cell suspension. The mixture of single cells was then
replated using identical conditions.
Neurosphere differentiation
Neurospheres were collected and plated onto poly-L-ornithine
(15 μg/ml) coated sterile coverslips (Nunc, Naperville, IL) in
EGF and bFGF-2 free media at a density of 10 spheres per well
for 5–7 days. In some experiments, neurospheres were
dissociated into single cells and plated at a density of
2.5 × 104 cells/cm2 in EGF and bFGF-2 free media per well
for 5–10 days with media replenished every 2 days. Differen-
tiated cells were fixed and processed for immunofluorescence
or RT-PCR studies. Experiments were performed at passage 2
through 4 for immunofluorescence and RT-PCR studies.
Clonal generation of neurospheres
To demonstrate the multipotency of neural stem/progenitor
cells, we performed clonal analysis according to Ara et al.
(2010). Single-cell suspensions made from passage 3 neuro-
spheres derived from piglet SVZ were diluted in EGF and
bFGF-2 medium and plated in 96-well plates (1 cell per well).
Plates were scored 24 h later. All wells that contained only
one viable cell were marked and these wells were rescored
16–20 days later for the presence of spheres. Every 48 h, 50%
674 J. Ara, S. De montpellierof the growth medium was exchanged for fresh medium. The
spheres were transferred onto poly-L-ornithine (15 μg/ml)
coated sterile coverslips (1 sphere/coverslip) and differenti-
ation was induced inmedium by omitting EGF and bFGF-2. The
differentiated spheres were processed for triple and double
labeling immunofluorescence.
For subcloning experiments, primary neurospheres were
extracted, individually dissociated and the resulting single cell
suspension from each neurosphere (200 cells/ml/well) were
plated into individual wells of a six-well plate for quantitative
determination of the frequency of secondary spheres. Some of
the secondary spheres were processed for second subcloning
step to generate tertiary spheres.
Neurosphere quantitation
Cells were cultured for the in vitro neurosphere assay (Reynolds
and Weiss, 1996) under clonal conditions as described above.
Cells were plated at 10 cells/μl in 24-well (0.5 ml/well) plates
in DMEM/HAMS F12 supplemented with 20 ng/ml epidermalFig. 4 Hypoxic-preconditioning increases the proliferation of neur
marker Tuj1 (A) or astrocytic marker GFAP (B) incorporated Brd
novo-generated from proliferating NSP cells. (C) Quantitative analys
PC + HI piglets positive for BrdU in early passages, whereas only 3
means ± SD of four independent experiments, derived from four dif
⁎P b 0.05 NX vs PC, NX vs HI and NX vs PC + HI; #P b 0.05 HI vs PC +growth factor (EGF), 20 ng/ml human basic fibroblast growth
factor 2, (bFGF-2), 2% B-27 supplement and penicillin G/
streptomycin sulphate/amphotericin. The total number of
spheres that formed in each well was counted after 10 days;
only colonies N100 μm in diameter were counted as spheres.
Ten random fields were counted per well. The frequency of
sphere forming cells (i.e. NSPs) was calculated from the
average number of spheres per field, the area of the field,
and the area of the well.
Detection of gene expression by RT-PCR analysis
For RT-PCR analysis, undifferentiated and differentiated
neurospheres derived from four different NSP preparations
were collected, washed twice with phosphate buffered saline
(PBS), pelleted and subjected to RNA isolation according to
Ara et al. (2010). Total RNA was isolated using QIAGEN RNeasy
Mini reagent kit (Qiagen, CA). The purity and integrity of the
RNA preparation was checked using spectrophotometer and by
1% formaldehyde-agarose gel electrophoresis. First-strandal stem/progenitor cells in vitro. Cells positive for the neuronal
U indicating that both neuronal and glial precursors are de
is of BrdU-positive progenitor cells showed over 45% of NSPs from
0% cells were BrdU positive in HI piglets. Data are reported as
ferent NSP preparations from four individual piglet SVZ's/group.
HI.
Fig. 4 (continued).
675Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitorscomplementary DNA (cDNA) was synthesized from 1 μg of
total RNA using SuperscriptTM II reverse transcriptase and
oligo (dT) 18 primers (Invitrogen Corporation, San Diego, CA).
The transcripts that encode CD133 (prominin 1), proliferation
marker Ki67, nestin, vimentin, Sox2 (SRY-box containing gene
2), Tuj1 (class III β-tubulin), microtubule-associated protein
Dcx (double cortin), and GFAP (glial fibrillary acidic protein)
were amplified by polymerase chain reaction (PCR). PCRproducts were run on 1.5% agarose gels and their size was
estimated using a 100-bp ladder.Immunocytochemistry
For immunocytochemical studies, EGF and bFGF-2 generated
individual primary neurosphere was transferred onto poly-L-
Fig. 5 Hypoxic-preconditioning increases the number of BrdU positive cells in newborn piglet brain. (A) Shows the BrdU
incorporation of neural stem/progenitor cells in SVZ after one week of recovery following repeated administration of BrdU injections.
(B) The number of BrdU-positive cells/mm2 (following a single injection of 50 mg/kg, 2 h before sacrifice) increased in the
subventricular zone (SVZ), White matter and Striatum of newborn piglet brain at 1, 3 and 7 days of recovery post hypoxic-
preconditioning. (C) Following repeated administrations; BrdU-labeled cells were significantly increased in the SVZ, striatum and
white matter at 7 days of recovery following hypoxic-preconditioning. Data are reported as means ± SD in four sections from each
piglet brain with four animals per group. ⁎P b 0.01 NX vs PC; ⁎P b 0.01 NX vs HI; ⁎P b 0.01 NX vs PC + HI and #P b 0.05 HI vs PC + HI.
676 J. Ara, S. De montpellierornithine coated 13 mm coverslips as previously reported
(Ara et al., 2010). The neurospheres were fixed, washed and
blocked with 5% normal goat serum in PBS with 0.1% triton
X-100 and processed for immunocytochemistry with anti-
bodies to intermediate filament nestin (Millipore, MA, 1:100
dilution). Cells were washed and incubated with biotinylated
goat anti-rabbit IgG followed by streptavidin. The cells were
counterstained with nuclear dye Hoechst 33258 (2 μg/ml)
for 5 min and mounted in Vectashield (Vector laboratories,
Burlingame, CA). For assessment of nonspecific staining, theprimary antibody was omitted and replaced with rabbit
primary antibody isotype control (Life Technologies, Grand
Island, NY).
Neurospheres were also processed for neural stem/
progenitor markers Sox2 and a proliferation marker Ki67.
Neurospheres were immunostained for Sox2 (mouse IgG,
Abcam Inc. Cambridge, MA, 1:100 dilution) and Ki67 (Santa
Cruz Biotechnologies, Santa Cruz, CA, 1:100 dilution) for 30 min
at room temperature. Cells were washed and incubated with
biotinylated secondary antibodies followed by streptavidin.
677Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitorsTo assess the differentiation potential of neurospheres,
single primary neurosphere was transferred onto poly-L-
ornithine (15 μg/ml) coated sterile coverslips and differentia-
tionwas induced in EGF and bFGF-2 freemedium for 5–10 days.
Differentiated neurospheres were immunostained live for
oligodendroglial progenitor marker O4 (hybridoma superna-
tants, mouse IgM, a gift from Dr. Judy Grinspan, 1:20 dilution)
under non-permeabilized conditions, or after fixation with 4%
paraformaldehyde and permeabilization with 0.1% Triton
X-100 for anti-Tuj1(rabbit IgG, Covance, CA, 1:500 dilution)
or anti-GFAP (mouse IgG, Millipore, MA, 1:200 dilution) to
identify neurons and astrocytes respectively. For double
labeling of Tuj1 and O4 or GFAP and O4, live cells were
incubated with O4 antibody, washed and incubated with
anti-FITC-conjugated anti-mouse IgM. Cells were washed,
blocked with 5% normal goat serum in PBS with 0.1% triton
X-100 and incubated in primary antibody against Tuj1 or GFAP.
A rhodamine-conjugated goat anti-rabbit IgG secondary
antibody was used to detect Tuj1 staining and rhodamine-
conjugated anti-mouse IgG was used to detect GFAP staining.
For Tuj1 and GFAP double staining, cells were fixed with 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100, and
then blocked with 5% normal goat serum for 15 min at room
temperature. The cells were incubated in primary antibodies
against Tuj1 and GFAP together followed by a secondary
antibody for FITC-conjugated-anti-rabbit IgG and rhodamine-
conjugated anti-mouse IgG to detect Tuj1 and GFAP,
respectively. The cells werewashed in PBS and counterstained
with nuclear dye Hoechst for 5 min and mounted in
Vectashield. Secondary antibodies for all immunofluorescent
staining were obtained from Jackson Immunoresearch labora-
tories,West Grove, PA. For control immunochemistry, primary
antibody was replaced with a specific immunoglobulin isotype
control antibody. The expression of each antigen was
examined in separate experiments at least three times.5-Bromo-2-deoxyuridine incorporation and detection
Cell proliferation was estimated by using 5-Bromo-2-
deoxyuridine (BrdU). Neurospheres were trypsinized and
plated on poly-L-ornithine coated coverslips and were
cultured for 20 h in the presence of 30 μg/ml of BrdU prior
to immunostaining. Cells were fixed with 70% ethanol for
30 min at −20 °C and then denatured by incubation in 2 N
HCl for 30 min at room temperature followed by extensive
rinses in 0.1 M borate buffer, pH 8.5. The cells were then
incubated with monoclonal anti-BrdU (1:100; Santa Cruz
Biotechnology Inc, Santa Cruz, CA) alone or double stained
for either BrdU/Tuj1 or BrdU/GFAP or BrdU/O4 for 40 min
at room temperature. Cells were washed and incubated with
secondary antibodies conjugated to appropriate fluorochromes
(Jackson Immunoresearch, West Grove, PA) for 30 min. After
five washes with PBS, cells were counterstained with nuclear
dye Hoechst 33258 and mounted with Vectashield. BrdU
positive cells were counted in 10 random fields of three
coverslips and percent positive was calculated by dividing the
positive cells by the total cell number.
Progenitor cell proliferation in vivo was estimated by
injecting above-mentioned groups of piglets (n = 4) with BrdU
(Sigma, 50 mg/kg body weight, 10 mg/ml in 0.007 N NaOH in
0.9% NaCl) intraperitoneally. Two BrdU staining paradigmswere used. Paradigm one was used to identify the phenotype
and location of S-phase cells at 1, 3, and 7 days by pulsing
single BrdU injections at the time point of interest followed by
sacrifice 2 h later. The second paradigm involved BrdU
injections at 8 h intervals twice daily starting day 1 of
recovery for 5 consecutive days followed by sacrifice at
7 days after initial injection to determine cell fate, pheno-
type, survival and migration of cells. The piglets were
anesthetized and transcardially perfused for single and double
immunofluorescence labeling.
For immunohistochemical analysis of BrdU, the 5-μm
paraffin sections were pretreated with 2 N HCl followed by
extensive rinses in 0.1 M borate buffer. Sections were
incubated overnight with anti-BrdU antibody. Sections were
also stained using a rabbit anti-Dcx antibody (1:100; Santa
Cruz Biotechnology Inc, Santa Cruz, CA) for a marker of
migrating neuroblasts. After washing, sectionswere incubated
for 1 h with biotinylated secondary antibodies followed by
streptavidin for 30 min at room temperature. The sections
were counterstained with Hoechst and mounted in
Vectashield. For double labeling of BrdU/Dcx, BrdU/GFAP
and BrdU/nestin, sections were pretreated in 2 N HCl for
60 min, rinsed in 0.1 M borate buffer and incubated in primary
antibody against BrdU. The sections were washed, and
incubated with rhodamine-conjugated anti-rat IgG (Jackson
Immunoresearch, West Grove, PA) for 1 h at room tempera-
ture. Sections were then subsequently stained using anti-Dcx
to identify immature neurons, anti-GFAP to identify astrocytes
and anti-nestin to identify NSPs. After washing, sections were
incubated with FITC-conjugated anti-rabbit or anti-mouse-
IgG. The cells were counterstained with Hoechst for 5 min and
mounted in Vectashield.
Quantification of BrdU immunostaining
The BrdU-positive cells were counted in tissue sections
counterstained with Hoechst 33258 and quantification was
performed in four sections from each piglet brain by an
independent investigator. In each case, the area of the SVZ,
white matter and striatum was traced and measured in square
millimeters using image J software (NIH, Bethesda, MD). The
total number of BrdU-positive cells in the selected areas were
counted and divided by the area to obtain a measurement of
cells per mm2. The values of cell counts are presented as
means ± SD and statistical analysis was conducted using
one-way analysis of variance (ANOVA) followed by Bonferroni's
multiple-comparisons post-test.
Statistical analysis
For quantification of the percentage of cells producing a given
marker, in any given experiment, the numbers of immunore-
active cells were determined relative to the total number of
Hoechst-labeled nuclei. Three coverslips were evaluated for
each type of marker and five random fields of each coverslip
were analyzed. Each field contained 100–200 cells. Results
were analyzed for statistical significance using analysis of
variance (ANOVA), and all error bars representing SDs of four
independent experiments, derived from four different neural
stem/progenitor cell preparations from four individual piglet
SVZ's/group. Post hoc test (Bonferroni's multiple-comparison
678 J. Ara, S. De montpelliertest) was carried out to analyze means between four
independent experiments of cell preparations. P values
b0.05 were considered significant.
Results
Hypoxic-preconditioning increases the number of
colony-forming neural stem/progenitor cells derived
from SVZ of neonatal piglet brain
We first characterized NSPs at 24 h recovery after NX, PC,
HI, and PC + HI in newborn piglet brain as described in Ara
et al. (2010). SVZ derived NSPs proliferated and formed freeFig. 6 (A) Doublecortin immunoreactivity in SVZ is increased in
Dcx-positive cells (red) were more abundant in the SVZ of precond
(PC + HI) piglets compared with the hypoxic–ischemic (HI) and no
50 μm. (B) Doublecortin immunoreactivity in cortex is increased in h
positive cells were more abundant in the neocortex of preconditione
HI piglets. Scale bar 50 μm.floating neurospheres, which grew in size over time in
response to mitogen EGF and bFGF-2 (Fig. 1A, Panel a).
During subsequent subcultures, the floating spheres could
be dissociated into single cells and proliferated to generate
new spheres. These cells could also generate neurospheres
when cultured at a density of one cell per well, confirming
that neurospheres resulted from expansion of individual clones
rather than from aggregation of cells. Clonal analyses
performed on NX, PC, HI and PC + HI NSPs yielded between
4.0 and 9.5% primary sphere-forming efficiency. The
frequency of secondary and tertiary neurosphere genera-
tion was also between 5 and 9%. When single spheres were
plated onto poly-L-ornithine coated glass coverslips in
24-well culture plates in the absence of mitogen EGF andhypoxic-preconditioned newborn brain at 7 days of recovery.
itioned (PC) and preconditioning followed by hypoxia–ischemia
rmoxic (NX) piglets at 7 days. LV = lateral ventricle. Scale bar
ypoxic-preconditioned newborn brain at 7 days of recovery. Dcx
d animals after one week of recovery compared to that of NX and
Fig. 6 (continued).
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entiatedwithin a few days (Fig. 1A, Panel b). These cells could
also be grown as adherent monolayers. Both adherent cells
and spheres exhibited morphological characteristics consis-
tent with other mammalian neural progenitor cultures.
We next studied whether NSPs derived from preconditioned
and hypoxic–ischemic SVZ express markers that are indicative
of an undifferentiated state. Using a rabbit polyclonal antibody
against nestin, an intermediate filament protein which is an
early marker for nondifferentiated neural progenitors, we
found that more than 80% of cells forming the neurosphere
were positive for nestin. Fig. 1A (Panel c), shows the nestin
positive neurospheres (green) and Hoechst labeled nuclei
(blue) generated from NX, PC, HI and PC + HI SVZ in the
presence of growth factors, EGF and bFGF-2. These results
verify that EGF and bFGF-2 induces the proliferation of
undifferentiated neural stem/progenitor cells derived from
SVZ of newborn piglet brain.
Cells were isolated from SVZ of PC, HI and PC + HI piglet
brain for the in vitro neurosphere assay under clonal
conditions to determine whether there was a concomitant
increase in the number of sphere forming cells after PC
compared to normoxic controls. Cells were plated at
10 cells/μl in 24-well (0.5 ml/well) plates in DMEM/HAMSF12 supplemented with EGF and bFGF-2. The total number
of spheres that formed in each well was counted after
10 days. Quantitative analysis of the neurospheres re-
vealed a significant increase in the number of spheres
derived from PC and PC + HI piglet SVZ after 24 h recovery
compared with the number of spheres derived from control SVZ
(P b 0.05, Fig. 1B). Twice as many neurospheres were
generated from the SVZ of piglets following PC and from piglets
that were preconditioned 24 h prior to HI than from normoxic
SVZ (PC, 395 ± 32; PC + HI, 380 ± 55 compared with NX, 190 ±
30) (Fig. 1B). The number of neurospheres generated from the
SVZ of PC + HI piglets was 1.4-fold higher than that of HI SVZ
(380 ± 55 compared with 275 ± 35) and the number of spheres
generated from HI SVZ was 1.5 fold higher than normoxic
controls (275 ± 35 compared with 190 ± 30) (Fig. 1B).Neural stem/progenitor cells derived from pre-
conditioned and hypoxic–ischemic neonatal piglet
SVZ express neural progenitor and neural differ-
entiation associated markers and genes
Passage three individual neurospheres were transferred
onto poly-L-ornithine coated sterile coverslips and one
Fig. 6 (continued).
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progenitor marker Sox2 and a proliferation marker Ki67.
Immunofluorescence studies showed the expression of Sox2 as
well as the presence of proliferation marker Ki67 in NSPs
derived from PC, HI and PC + HI SVZ (Fig. 2A).
Total RNA from primary neural stem/progenitor cell
cultures derived from NX, PC, HI and PC + HI neonatal piglet
SVZ was examined by RT-PCR for the expression of established
neurodevelopmental markers. We investigated the expression
of the stem/progenitor cell markers and neural differentiation
markers in these cells. The piglet NSP cultures exhibited the
expression of nestin, vimentin, CD133 and nuclear transcrip-
tion factor Sox2, as well as the proliferation marker Ki67
(Fig. 2B). These cells also expressed cytoskeletal associated
proteins double cortin (Dcx), an immature neuronmarker Tuj1,
and astrocyte marker GFAP. In each case after PCR, a single
product of a size appropriate for the target RNA was present,
indicating that neonatal piglet SVZ derived neurospheres
express each of these neural stem/progenitor cell and neural
differentiation associated genes (Fig. 2B).Neural stem/progenitor cells derived from pre-
conditioned and hypoxic–ischemic neonatal piglet
SVZ are multipotent
In order to demonstrate the multipotency of piglet SVZ
derived NSP cells from PC, HI and PC + HI piglet, we
performed a clonal analysis. We examined whether NSPs
had the potential to differentiate into cells with neuron,
astrocyte, and oligodendrocyte characteristics. Single
primary EGF and bFGF2-generated spheres were stained
with lineage-specific markers, Tuj1 (a marker for neu-
rons), GFAP (a marker for astrocytes) and O4 (a marker for
immature oligodendrocytes). Double immunolabeling of
clonally derived spheres with antibodies to Tuj1 and GFAP
or Tuj1 and O4 or GFAP and O4 revealed that differenti-
ated NSPs are multipotent with populations of neurons,
astrocytes and oligodendrocytes (Fig. 3).
The percentage of neurons and astrocytes generated
from NSPs from PC alone or PC + HI was significantly
greater than the percentages generated from NSPs from
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neurons was ~1.6 and 1.5 fold higher in NSPs from PC and
PC + HI respectively compared to that of normoxic SVZ (PC,
66 ± 8%; PC + HI, 64 ± 12% compared with NX, 42 ± 5%;
P b 0.05). The percentage of astrocytes was ~1.3 fold
higher in PC and PC + HI NSPs compared to normoxic
controls (PC, 40 ± 8%; PC + HI, 42 ± 7% compared with NX,
32 ± 5%; P b 0.05). The percentage of neurons and astro-
cytes in PC + HI NSPs increased ~1.2 fold over that of HI
NSPs (PC + HI, 64 ± 12% compared to HI, 55 ± 10% (neurons)
and 42 ± 7% compared to 35 ± 5% (astrocytes) respectively
(P b 0.05, Table 1). We did not observe significant differences
in the percentages of oligodendrocytes between the four
groups (Table 1).
NSP proliferation increases in newborn brain following
hypoxic-preconditioning
To analyze the proliferative capacity of NSPs isolated from PC,
HI and PC + HI piglet SVZ, we used bromo-deoxyuridine
(BrdU), which is selectively incorporated by cells during S
phase ofmitosis. Cells positive for the neuronalmarker Tuj1 or
astrocytic marker GFAP incorporated BrdU (Figs. 4A and B),
indicating that both neuronal and glial precursors are de
novo-generated from proliferating progenitor cells. There was
a significant increase in BrdU positive cells in PC and PC + HI
animals compared to normoxic controls. NSPs from PC piglets
showed 30% higher BrdU positive cells than normoxic NSPs
(36 ± 4.5% compared with 25.0 ± 5.0%; P b 0.05) (Fig. 4C).
There was a 40% increase in BrdU positive NSPs from PC + HI
piglets compared to normoxic controls in early passages (44 ±
6.0% compared with 25.0 ± 5.0%; P b 0.05), and 25% increase
in BrdU positive NSPs in HI piglets (33.0 ± 6.0% compared with
25.0 ± 5.0%; P b 0.05) (Fig. 4C). The percent of BrdU/Tuj1
(16 ± 2.0%) and BrdU/GFAP (12 ± 2.0%) double-labeled cells
from PC + HI SVZ were significantly increased (P b 0.05)
compared to the percent from HI (9 ± 1.0% for BrdU/Tuj1
and 8 ± 1.0% for BrdU/GFAP).
Hypoxic preconditioning increases progenitor cell
proliferation in vivo
BrdU labeling studies were performed to assess PC-induced
SVZ cell proliferation in vivo. Pulsing single BrdU injections
at the time point of interest followed by sacrifice 2 h later or
injecting BrdU at 8 h intervals twice daily for 5 consecutive
days resulted in BrdU incorporation into the replicated DNA
molecules and labeling of proliferating progenitor cells.
After 1, 3 days or one week of recovery from PC or PC
performed 24 h prior to HI insult; there was an increased
proliferation of cells in the SVZ, striatum and white matter
as revealed by increased BrdU uptake (Fig. 5). Fig. 5 shows
the numbers of BrdU-positive cells in NX, PC, HI and PC + HI
animals in SVZ, white matter and striatum following single
(Fig. 5B) and repeated administration (Fig. 5C) of BrdU
injections. The number of BrdU positive cells increased
significantly (P b 0.05) in SVZ of PC group at 24 h, 3 days and
7 days compared to normoxic controls with single BrdU
injection paradigms. In HI group, the number of BrdU
positive cells were significantly higher at 24 h and 3 days
compared to normoxia, however, at 7-day recovery, therewas no difference in BrdU positive cells between the two
groups. In PC + HI group the number of BrdU positive cells in
SVZ increased by 1.66 fold, 1.6 fold and 2.0 fold at 24 h, 3
and 7 days of recovery respectively compared to normoxia
and by 1.2 fold, 1.4 fold and 2.0 fold compared to HI group
(Fig. 5B). In subcortical white matter and striatum, there
was a significant increase in BrdU positive cells in PC group
at 3 and 7 days compared to normoxia. In PC + HI group, the
BrdU positive cells were significantly higher (P b 0.05,
Fig. 5B) at 3 and 7 days in white matter and striatum
compared to normoxic group and significantly higher
(P b 0.05) at 3 and 7 days in white matter and at 7 days in
striatum compared to HI group.
Following repeated BrdU administration, the number of
BrdU labeled cells in SVZ, white matter and striatum
increased significantly after PC and PC + HI compared to
normoxia (Fig. 5C). Quantitatively, BrdU positive cells in
SVZ, white matter, and striatum increased by 2.1 fold, 3.9
fold and 4 fold respectively in PC group compared to
normoxic group. In HI group there was 1.4 fold, 3 fold, and
2.5 fold increase in BrdU positive cells in SVZ, white matter
and striatum respectively (Fig. 5C). The number of BrdU
positive cells in SVZ, white matter and striatum of PC + HI
group increased by 3.3 fold, 6 fold, and 4.2 fold compared to
normoxic controls at 7 days of recovery. Furthermore, the
BrdU-labeled cell numbers in the SVZ, white matter and
striatum of PC + HI animals was significantly higher (2.5
fold, 2 fold, and 1.7 fold respectively, P b 0.05, Fig. 5C) than
that of non-preconditioned (HI) animals. These results
suggest that hypoxic-preconditioning performed 24 h prior
to HI may promote progenitor cell proliferation in newborn
piglet brain, contributing to the repair of the injured brain.Hypoxic preconditioning increases neurogenesis in
vivo
To investigate whether there is an increase in neurogenesis
in vivo after PC and HI, we evaluated Dcx expressing cells
in the SVZ, neocortex (Figs. 6A and B) and striatum
(Supplementary Fig. S6C) of newborn piglet brain. After
1 week of recovery, there were significantly more Dcx-
immunostained cells in the SVZ of PC and PC + HI piglets
compared with the HI and normoxic SVZ (Fig. 6A). Statistical
analysis showed that the number of Dcx-positive cells in the
SVZ of PC and PC + HI groups (387 ± 92 and 420 ± 102/mm2)
displayed a significant increase (1.5 fold and 1.6 fold
respectively; P b 0.05) compared with the normoxic group
(264 ± 65/mm2) one week after recovery. Furthermore, the
Dcx-positive cell numbers in the SVZ of PC + HI animals was
significantly higher (420 ± 102/mm2; P b 0.01) than that of
non-preconditioned (HI) animals (311 ± 76/mm2). In PC and
PC + HI animals, a large number of Dcx positive cells with
morphologies of migrating neuroblasts were found in
striatum, which appeared to be migrating from the SVZ
(Fig. S6C). Dcx positive cells with migratory profiles were
rare in the normoxic striatum. A large number of the Dcx
positive cells in PC (62 ± 20/mm2; P b 0.05) and PC + HI
animals (78 ± 27/mm2; P b 0.05) migrated into the neocor-
tex compared to normoxic (38 ± 10 mm2) and HI animals
(50 ± 15 mm2) (Fig. 6B). After BrdU injections, the numbers
of BrdU/doublecortin (Fig. 7A), BrdU/nestin (Fig. 7B), and
682 J. Ara, S. De montpellierBrdU/GFAP (Fig. S7C) double-labeled cells also increased after
PC (Table 2). The proportion of BrdU+-Dcx+, BrdU+-Nestin+ and
BrdU+-GFAP+ double-labeled cells among BrdU-positive cells in
the PC and PC + HI animals was significantly higher compared
to normoxic or HI groups (Table 2; P b 0.05). These results
suggest that PC may contribute to postnatal neurogenesis by
modulating the proliferation and fate of SVZ neural/progenitor
cells.Discussion
The present investigation demonstrates a comprehensive
evaluation of the effects of hypoxic-preconditioning and
hypoxia–ischemia subsequent to preconditioning on prolif-
eration, differentiation and neurogenesis of NSPs resident
in subventricular zone both in vitro and in vivo. Our data
establishes that NSPs derived from SVZ of newborn piglets
pretreated with preconditioning prior to hypoxia–ischemia
formed greater number of neurospheres, generated twice
as many neurons and astrocytes in vitro, and increased
proliferation and neurogenesis in SVZ, striatum and white
matter of newborn piglet brain in vivo. To the best of our
knowledge this is the first study that utilized an in vivoFig. 7 Double immunolabeling of BrdU positive cells with double co
7 days of recovery. Images from the same panel showing BrdU (re
separately and as merged images for the control, PC, HI and PC + Hpiglet model of hypoxic-preconditioning-induced ischemic
tolerance to demonstrate that PC induces proliferation and
neurogenesis in newborn brain after hypoxic–ischemic
injury.
Neurogenesis by NSPs and survival of newly differentiated
cells can contribute to self-repair after neuronal loss (Arvidsson
et al., 2002; Jin et al., 2003; Nakatomi et al., 2002; Sun et al.,
2007). The process can be stimulated in response to CNS injury
such as ischemic, traumatic, and inflammatory brain injury
(Dempsey et al., 2003; Gould et al., 1997; Gu et al., 2000; Jin et
al., 2001; Liu et al., 1998; Parent et al., 1997) and by signaling
from astroglia (Song et al., 2002). However, spontaneous brain
regeneration is inefficient to fully compensate for the neuronal
loss observed in CNS disorders (Bjorklund and Lindvall, 2000).
Activating the pathways governing restorative responses with
select stimulants might enhance this process such that
substantial functional tissue regeneration can occur. One of
the strategies to activate endogenous repair systems is
hypoxic-preconditioning, which activates an adaptive response
that prepares the brain to minimize damage and promote
regeneration in the event of future ischemic insult. Hypoxic-
preconditioning, a sublethal hypoxic stimulus can also reduce
infarct size and ameliorate neurologic deficits and, being sub
threshold, does not induce cell death (Stenzel-Poore et al.,rtin (A) and nestin (B) in NX, PC, HI and PC + HI piglet brain after
d), Dcx (green, 7A), and nestin (green, 7B) immunoreactivity
I groups. Scale bar 50 μm. LV = lateral ventricle.
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proliferating precursors in the brain (Jin et al., 2001). The
presence of newly generated neuronal and glial precursors
(Naylor et al., 2005) after transient or prolonged ischemia has
been interpreted as a restorative response of the brain to
injury (Martino and Pluchino, 2006). PC can be used as an
experimental strategy to identify mechanisms for brain
protection with the purpose of therapeutically exploiting
such mechanisms by boosting or exogenously substituting
endogenous protectants following ischemia.
Our previous study (Ara et al., 2011) demonstrated the
protective efficacy of hypoxic-preconditioning against hypox-
ic–ischemic injury in newborn piglet model. We showed that
hypoxic exposure for 3 h, 24 h before hypoxia–ischemia, was
effective in reducing brain damage in newborn piglets while
itself causing no morphologic evidence of neuronal injury.
Preconditioning performed 24 h prior to severe hypoxia–
ischemia reduced the neuronal loss in all the brain regions
studied at 3 and 7 days after cerebral hypoxia–ischemia (Ara et
al., 2011). Here, we studied the induction of neurogenesis in
response to hypoxic-preconditioning treatment at 1 day,
3 days and one week after neonatal HI brain injury.
To address the question of the potential role of ischemic
tolerance in progenitor cell proliferation, we used BrdU, ananalog of thymidine. After 1, 3 days or one week of recovery
from PC or PC performed 24 h prior to HI insult; there was an
increased proliferation of cells in the SVZ, striatum and white
matter as revealed by increased BrdU uptake, as well as by
increased numbers of nestin-positive cells in the entire SVZ.
These new cells were found to express neuronal and astrocytic
markers, double cortin or GFAP. This increase in cells in
S-phase within the region of the SVZ that harbors the stem/
progenitor cells correlates with a doubling of the number of
tripotential, self-renewing NSPs as measured using the
neurosphere assay. BrdU incorporation assay in vitro demon-
strated that hypoxic treatment enhanced BrdU incorporating
into NSPs, and the cells positive for the neuronal marker Tuj1
or astrocytic marker GFAP incorporated BrdU during differen-
tiation, indicating that both neuronal and glial precursors are
de novo-generated from proliferating progenitor cells. Though
BrdU may potentially indicate DNA repair (Rakic, 2002), the
mildness of the hypoxic episode, the long delay between
exposure to hypoxia and BrdU injection, the dose of BrdU
administered as well as the marked augmentation of its
incorporation rate into the germinative SVZ strongly suggest
that BrdU labeling actually reflects proliferating cells.
The present study shows that PC also induces neurogenesis
in newborn piglet brain. Our data show that dividing Dcx
Fig. 7 (continued).
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cells withmorphologies ofmigrating neuroblasts were found in
striatum and also migrated to neocortex, suggesting that the
SVZ is the main source of new neurons in the neocortex.
Nonetheless, we cannot exclude the possibility that some of
the newly generated neurons are derived from local pre-
cursors or from glial progenitors that dedifferentiate and
become respecified as neurons. Furthermore, prior PC
augmented the increase in neurogenesis that occurred in the
post-hypoxic–ischemic brain. These findings are largely
consistent with previous studies unequivocally showing that
various stresses, including hypoxia, can induce neurogenesis.
Global and focal ischemic brain injuries in adult animals have
been demonstrated to trigger compensatory neurogenesis
from neural stem cells or progenitor cells located in
germinative areas such as the hippocampal dentate gyrus or
the SVZ (Kokaia and Lindvall, 2003). According to Nakatomi et
al. (2002), these cells originating from the SVZ are capable to
migrate and to incorporate the hippocampal circuitry. Further
studies have shown that neonatal hypoxia for 5 min strongly
stimulated the generation of new cells in the SVZ within the
ensuing three weeks, and demonstrated that newly formed
cells gave rise to additional functional neurons (Pourie et al.,
2006). A study by Lee et al. (2007) also observed increasedneurogenesis in adult Sprague–Dawley rat brain at 4–7 days of
reperfusion following PC induced by a 10 min transient middle
cerebral artery occlusion. Considering our findings that
greater number of neurons were newly generated after PC
treatment, PC-induced neurogenesis might offer a potential
means of replacing damaged neurons. In addition, the presence
of more robust neurogenesis in the PC + HI group despite a
lower level of tissue injury than in the HI group indicates that
neurogenesis may not be correlated with tissue injury. This is
consistent with the conclusion drawn by Arvidsson et al. (2001)
who outlined that enhanced neurogenesis in adult rats
following stroke was not correlated to the extent of brain
damage.
In conclusion, the present study utilized an in vivo piglet
model of hypoxic-preconditioning-induced ischemic toler-
ance to demonstrate that PC induces proliferation and
neurogenesis of endogenous NSPs up to 7 days after the
hypoxic–ischemic insult. PC appears as a broad, non-invasive
and reproducible strategy to prime the endogenous NSPs to a
state of “readiness” by stimulation of their survival signaling
pathways before introduction into ischemic environment.
The signaling pathways involved in PC can be successfully
employed for developing new therapeutic interventions to
enhance endogenous neurogenesis after HI brain injury.
Table 2 BrdU positive cells that co-labeled with each
cell-type marker in the SVZ of newborn piglet brain.
Groups Number of cells/mm2 (SVZ)
BrdU+-Dcx+ BrdU+-nestin+ BrdU+-GFAP+
Normoxia 18 ± 7 36 ± 7 15 ± 5
PC 77 ± 20 a 205 ± 34 a 64 ± 20 a
HI 39 ± 16 a 107 ± 22 a 39 ± 12 a
PC + HI 112 ± 21 a b 285 ± 45 a b 95 ± 23 a b
a P b 0.05 or b0.01 Nx vs PC, NX vs HI and NX vs PC + HI.
b P b 0.05 HI vs PC + HI.
685Hypoxic-preconditioning enhances the regenerative capacity of neural stem/progenitorsFuture advances in terms of identifying key molecular
mediators present the possibility of improving functional
outcome in hypoxic–ischemic and stroke patients. Growth
factors and other proliferation-inducing molecules might be
synthesized by the astroglial and the surviving neurons in the
cortex and striatum and could diffuse into the neurogenic
regions of the brain. This concept is strengthened by the recent
observations from our laboratory showing increased vascular
endothelial growth factor expression in the neurons and
astrocytes throughout the newborn piglet brain subjected to
hypoxic-preconditioning (Ara et al., 2011). Sun et al. (2003)
showed that VEGF enhanced the delayed survival of newborn
neurons in the dentate gyrus and subventricular zone after
ischemia. Future studies involving the modulation of adaptive
response of brain to ischemic injury by exogenous growth
factor treatment or by altering the expression of growth
factors will be required to determine more definitively
whether above paradigms will help to increase cerebral
ischemia or stroke-induced neurogenesis.
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